The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.
Investing News Network on MSN2d
Pharma Market Forecast: Top Trends for Pharma in 2025The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ...
News Medical on MSN7d
Typical cost of developing new pharmaceuticals is skewed by high-cost outliersThe pharmaceutical industry argues that lower prices will have catastrophic effects on research and development, while other suggest that curbing drug prices will result in only modest cuts in the ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS – Research Report), Quanterix ...
As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...
Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...
The new Aurobindo facility will expand the single-stream manufacturing process of generic pharmaceuticals from manufacturing, ...
US biopharmaceutical company Athira Pharma, based in Washington state, has agreed to pay more than $4 million (£3.3 million) ...
Now, Pfizer and the trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) rank among the organizations that have helped Trump raise a record-setting $150 million in pledges ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback